Activation of the CXCL12/CXCR4 signaling axis may drive vascularization of the ovine placenta

被引:31
|
作者
Quinn, K. E. [1 ]
Ashley, A. K. [1 ]
Reynolds, L. P. [2 ]
Grazul-Bilska, A. T. [2 ]
Ashley, R. L. [1 ]
机构
[1] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA
[2] N Dakota State Univ, Ctr Nutr & Pregnancy, Dept Anim Sci, Fargo, ND 58108 USA
基金
美国食品与农业研究所;
关键词
CXCL12; CXCR4; VEGF; Vascularization; Pregnancy; Sheep; STROMAL-DERIVED FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; MATERNAL-FETAL INTERFACE; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; EARLY-PREGNANCY; TH2; BIAS; FACTOR-I; ANGIOGENESIS; EXPRESSION;
D O I
10.1016/j.domaniend.2013.12.004
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Early pregnancy, when most embryonic losses occur, is a critical period in which vital placental vascularization is established. Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis, and factors that regulate VEGF function, expression, or both may ultimately affect vascularization. Activation of the C-X-C chemokine receptor type 4 (CXCR4) by its cognate ligand, C-X-C chemokine ligand 12 (CXCL12), increases VEGF synthesis and secretion, which in turn stimulates CXCL12 and CXCR4 production and this synergistic regulation may influence placental vascularization. We hypothesized that expression of CXCL12, CXCR4, select angiogenic factors, and their receptors would increase in placental tissues during early pregnancy and that treatment of ovine trophectoderm cells with CXCL12 would increase production of angiogenic factors. To test this hypothesis, maternal caruncle (CAR) and fetal extraembryonic membrane (FM) tissues were collected on days 18, 20, 22, 25, 26, and 30 of pregnancy and on day 10 of the estrous cycle (control, NP) to determine relative mRNA or protein expression of CXCL12 and CXCR4 and selected angiogenic factors. In CAR, expression of mRNA for CXCR4 increased on day 18, 20, 22, and 25 and CXCL12 increased on day 18 and 20 compared with NP ewes. CXCL12 protein followed a similar pattern in CAR tissue, with greater levels on day 20 than in NP tissue. Greater levels of fibroblast growth factor 2 (FGF2) mRNA was observed in CAR on day 20 of gestation than on day 30. In FM, CXCL12, CXCR4, angiopoietin 1, VEGF, and VEGF receptor 1 were enhanced with advancing pregnancy, whereas FGF2 and kinase insert domain receptor (or VEGF receptor 2) peaked on day 25. An increase in protein levels occurred on day.25 compared with day 20 in FM for CXCL12 and CXCR4, as well as a similar tendency for FGF2 protein. Both CXCL12 and CXCR4 are specifically localized to trophoblast cells and to the uterine luminal and glandular epithelium. Treatment of ovine trophectoderm cells with CXCL12 increased mRNA expression for VEGF and FGF2. The relationship between VEGF, FGF2, and the CXCL12/CXCR4 signaling underscores the potential role for this chemokine axis in driving placentation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 50 条
  • [21] CXCL12 May Drive Inflammatory Potential in the Ovine Corpus Luteum During Implantation
    McIntosh, Stacia Z.
    Quinn, Kelsey E.
    Ashley, Ryan L.
    REPRODUCTIVE SCIENCES, 2022, 29 (01) : 122 - 132
  • [22] Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus
    Chong, Benjamin F.
    Mohan, Chandra
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (10) : 1147 - 1153
  • [23] CXCR4 and CXCL12 signaling regulates the development of extrinsic innervation to the colorectum
    Halasy, Viktoria
    Szocs, Emoke
    Soos, Adam
    Kovacs, Tamas
    Pecsenye-Fejszak, Nora
    Hotta, Ryo
    Goldstein, Allan M.
    Nagy, Nandor
    DEVELOPMENT, 2023, 150 (08):
  • [24] CXCL12/CXCR4 axis: an emerging neuromodulator in pathological pain
    Luo, Xin
    Wang, Xiaomin
    Xia, Zhengyuan
    Chung, Sookja Kim
    Cheung, Chi Wai
    REVIEWS IN THE NEUROSCIENCES, 2016, 27 (01) : 83 - 92
  • [25] CXCL12 and CXCR4 in bone marrow physiology
    Moll, Natalia M.
    Ransohoff, Richard M.
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (03) : 315 - 322
  • [26] SOX17 inhibits proliferation and invasion of neuroblastoma through CXCL12/CXCR4 signaling axis
    Wang, Xiao-Hui
    Zhang, Shu-Feng
    Wu, Hai-Ying
    Gao, Jian
    Wang, Xu-Hui
    Gao, Tian-Hui
    CELLULAR SIGNALLING, 2021, 87
  • [27] The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
    Smit, Martine J.
    Schlecht-Louf, Geraldine
    Neves, Maria
    van den Bor, Jelle
    Penela, Petronila
    Siderius, Marco
    Bachelerie, Francoise
    Mayor, Federico, Jr.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 541 - 563
  • [28] The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
    Garcia-Cuesta, Eva M.
    Santiago, Cesar A.
    Vallejo-Diaz, Jesus
    Juarranz, Yasmina
    Miguel Rodriguez-Frade, Jose
    Mellado, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [29] The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer
    Lee, Hyo Jin
    Jo, Deog Yeon
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (09) : 1155 - 1161
  • [30] Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review
    Bocchi, Mayara
    Pereira, Nathalia de Sousa
    de Oliveira, Karen Brajao
    Amarante, Marla Karine
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (07) : 6233 - 6239